Sign In
Search Icon
Menu Icon

Biomedical Advanced Research and Development Authority

The Biomedical Advanced Research and Development Authority (BARDA) provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks; pandemic influenza (PI), and emerging infectious diseases (EID).

Together with its industry partners, BARDA promotes the advanced development of medical countermeasures to protect Americans and respond to 21st century health security threats.

Partnering with BARDA

Program Areas


Innovation and Partnerships

CARB-X Logo  
DRIVe Logo  
Blue Knight Logo  
BARDA Ventures Logo  
Culture of Innovation Logo  

Meet the Director


Dr. Gary Disbrow is the Director of the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services. Read More


FDA approvals, licensures, and clearances

Enhancing the nation's preparedness by partnering with innovators to make countermeasures available.

Learn More »

Biomedical products supported for COVID-19 response

Responding to the COVID-19 pandemic by developing vaccines, therapeutics, and diagnostics to help fight the virus.

Learn More »

BARDA-supported COVID-19 Partnerships

COVID-19 CoronaWatch Virtual Market Research Meetings with innovative companies.

Learn More »